S233: AXICABTAGENE CILOLEUCEL AS SECOND-LINE THERAPY FOR LARGE B-CELL LYMPHOMA IN TRANSPLANT-INELIGIBLE PATIENTS: FINAL ANALYSIS OF ALYCANTE, A PHASE 2 LYSA STUDY.
Resource Type
Abstract
Authors
Houot, Roch ; Bachy, Emmanuel ; Cartron, Guillaume ; Gros, Francois-Xavier ; Morschhauser, Franck ; Oberic, Lucie ; Gastinne, Thomas ; Feugier, Pierre ; Duléry, Rémy ; Thieblemont, Catherine ; Joris, Magalie ; Jardin, Fabrice ; Choquet, Sylvain ; Casasnovas, Rene Olivier ; Brisou, Gabriel ; Cheminant, Morgane ; Bay, Jacques Olivier ; Llamas, Francisco ; Menard, Cedric ; Tarte, Karin
Source
HemaSphere; 2023 Supplement 3, Vol. 7, pe56791ba-e56791ba, 1p
Subject
Language
ISSN
25729241